Liver flukes produce cathepsin B and cathepsin L in their excretory-secretory material. These proteases are proposed to be key virulence factors for parasite infection, and are therefore targets for vaccination. Cathepsin B is predominately released in the juvenile stage of the life cycle, while different cathepsin L's are released throughout the cycle. Three proteases (cathepsin L5, cathepsin L1g and cathepsin B) were expressed in yeast from cDNA clones isolated from adult, metacercariae and newly excysted juvenile flukes respectively. Each was used singly or in combination to vaccinate rats that were subsequently challenged with Fasciola hepatica metercercariae. Each protein induced an immune response, and all groups vaccinated with ...
Fasciola hepatica infection causes important economic losses in livestock and food industries around...
The liver fluke, Fasciola hepatica causes liver fluke disease, or fasciolosis, in ruminants such as ...
Phage display technology to produce recombinant monoclonal antibodies or antibody fragments permits ...
Liver flukes produce cathepsin B and cathepsin L in their excretory–secretory material. These protea...
AbstractFasciola's excretory-secretory material comprises chiefly cathepsin B and cathepsin L. These...
Fasciola's excretory-secretory material comprises chiefly cathepsin B and cathepsin L. These cystein...
Fasciola hepatica juveniles express immunodominant cathepsin L proteins, which are mainly found in t...
Cathepsin L (CL)-like proteases are important candidate vaccine antigens for protection against helm...
Fasciola hepatica secretes cathepsin L proteases that facilitate the penetration of the parasite thr...
Fasciola hepatica secretes cathepsin L proteases that facilitate the penetration of the parasite thr...
Fasciola hepatica infection continues to be a major problem in the agriculture sector, particularly ...
Cathepsin proteases are promising vaccine or drug targets for prophylaxis or therapy against Fasciol...
The liver flukes Fasciola hepatica and F. gigantica cause infectious disease in ruminants and humans...
Background Cysteine proteinases of Fasciola hepatica are important candidates for vaccine antigens b...
The liver fluke, Fasciola hepatica, is one of the most important parasites of livestock, and it also...
Fasciola hepatica infection causes important economic losses in livestock and food industries around...
The liver fluke, Fasciola hepatica causes liver fluke disease, or fasciolosis, in ruminants such as ...
Phage display technology to produce recombinant monoclonal antibodies or antibody fragments permits ...
Liver flukes produce cathepsin B and cathepsin L in their excretory–secretory material. These protea...
AbstractFasciola's excretory-secretory material comprises chiefly cathepsin B and cathepsin L. These...
Fasciola's excretory-secretory material comprises chiefly cathepsin B and cathepsin L. These cystein...
Fasciola hepatica juveniles express immunodominant cathepsin L proteins, which are mainly found in t...
Cathepsin L (CL)-like proteases are important candidate vaccine antigens for protection against helm...
Fasciola hepatica secretes cathepsin L proteases that facilitate the penetration of the parasite thr...
Fasciola hepatica secretes cathepsin L proteases that facilitate the penetration of the parasite thr...
Fasciola hepatica infection continues to be a major problem in the agriculture sector, particularly ...
Cathepsin proteases are promising vaccine or drug targets for prophylaxis or therapy against Fasciol...
The liver flukes Fasciola hepatica and F. gigantica cause infectious disease in ruminants and humans...
Background Cysteine proteinases of Fasciola hepatica are important candidates for vaccine antigens b...
The liver fluke, Fasciola hepatica, is one of the most important parasites of livestock, and it also...
Fasciola hepatica infection causes important economic losses in livestock and food industries around...
The liver fluke, Fasciola hepatica causes liver fluke disease, or fasciolosis, in ruminants such as ...
Phage display technology to produce recombinant monoclonal antibodies or antibody fragments permits ...